Our results also confirmed higher survival for women with breast cancer positive to either oestrogen or progesterone receptors and negative to HER2 receptors, as well as worsening prognostic as grading increased from well to poorly differentiated tumour. The gene discussed is PGR; the disease is breast carcinoma.